AIP and pituitary tumor: However, other mechanisms that could modify the biology of the GH-secreting pituitary tumor cannot be excluded; recent studies have found that somatostatin analogs pretreatment modulate aryl hydrocarbon receptor interacting protein in somatotroph adenomas [47].